Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model.
about
Mesenchymal stromal cell therapy in COPD: from bench to bedside.RNA interference-based therapy and its delivery systems.Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia.miR-24 and miR-122 Negatively Regulate the Transforming Growth Factor-β/Smad Signaling Pathway in Skeletal Muscle Fibrosis.miR-21 modification enhances the performance of adipose tissue-derived mesenchymal stem cells for counteracting urethral stricture formationCell Therapy in Idiopathic Pulmonary Fibrosis
P2860
Modified mesenchymal stem cells using miRNA transduction alter lung injury in a bleomycin model.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Modified mesenchymal stem cell ...... g injury in a bleomycin model.
@en
type
label
Modified mesenchymal stem cell ...... g injury in a bleomycin model.
@en
prefLabel
Modified mesenchymal stem cell ...... g injury in a bleomycin model.
@en
P2093
P2860
P50
P1476
Modified mesenchymal stem cell ...... g injury in a bleomycin model.
@en
P2093
Diana Álvarez
Guoying Yu
Koji Sakamoto
Luai Huleihel
Maria G Kapetanaki
Mauricio Rojas
Nayra Cardenes
P2860
P304
P356
10.1152/AJPLUNG.00323.2016
P577
2017-04-06T00:00:00Z